Mealey's (June 13, 2018, 11:32 AM EDT) -- SAN DIEGO — A California appeals panel on May 31 granted a petition for relief filed by a group of pharmaceutical companies in relation to a district attorney’s allegations that they violated California’s unfair competition law (UCL) by engaging in a scheme to keep generic versions of a drug off the market, finding that a DA cannot seek monetary recovery for violations outside his elected county (Abbott Laboratories, et al. v. The Superior Court of Orange County, The People, ex rel., No. D072577, Calif. App., 4th Dist., 2018 Cal. App. LEXIS 507)....